FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...